Startups

Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.

Summary

Seedtable Score
  • 4
Locations
Company Size
  • 11 to 50 employees
Last Stage Round

Total funding Amount

$57M

Fundraising History

Investors